Gennova Biopharmaceuticals' COVID-19 vaccine has been found to be safe and effective in an early-stage study, according to India's drug regulator.

The company has been allowed to conduct further studies to test efficacy and other parameters. The Maharashtra-based pharmaceutical company plans to conduct a late stage trial at close to 25 sites in the country.

Leave a Reply

Your email address will not be published. Required fields are marked *